Cancer/Testis Antigen 1B (CTAG1B)
CTAG; CTAG1; ESO1; LAGE-2; LAGE2B; NY-ESO-1; CAMEL; ESO2; LAGE-1; LAGE-2b; LAGE2A; Autoimmunogenic cancer/testis antigen NY-ESO-1; L antigen family member 2
-98316.jpg)
Cancer/testis antigens, such as CTAG1B, are expressed in a variety of malignant tumors but soley in testis among normal adult tissues.
NYESO1 expression in primary MTC tissues significantly correlated with tumor recurrence. The presence of specific anti-NYESO1 antibodies was searched in the sera of MTC-affected patients examined by ELISA using recombinant NYESO1 protein. A humoral response against this CTA was detected in 6 of 11 NYESO1-expressing patients (54.5%), and in 1 of 6 patients with an NYESO1-negative tumor. Anti-NYESO1 antibodies were present in 15 of 42 sera (35.7%), demonstrating that MTC is a neoplasm frequently associated with humoral immune response to NYESO1.
Organism species: Homo sapiens (Human)
- Recombinant protein RPJ316Hu01 Recombinant Cancer/Testis Antigen 1B (CTAG1B) In Stock
- Recombinant protein RPJ316Hu02 Recombinant Cancer/Testis Antigen 1B (CTAG1B) In Stock
- Recombinant protein RPJ316Hu03 Recombinant Cancer/Testis Antigen 1B (CTAG1B) In Stock
- Monoclonal antibody MAJ316Hu21 Monoclonal Antibody to Cancer/Testis Antigen 1B (CTAG1B) In Stock
- Polyclonal antibody PAJ316Hu01 Polyclonal Antibody to Cancer/Testis Antigen 1B (CTAG1B) In Stock
- Polyclonal antibody PAJ316Hu02 Polyclonal Antibody to Cancer/Testis Antigen 1B (CTAG1B) In Stock
- Sandwich ELISA SEJ316Hu ELISA Kit for Cancer/Testis Antigen 1B (CTAG1B) In Stock